LeadIQ logo
Learn more at LeadIQ.com

Insights

Emerging Key Personnel Cue Biopharma recently appointed Lucinda Warren as the chief business officer, showcasing potential collaboration opportunities with new leadership.

Expanding Therapeutic Pipeline The development of therapeutic candidates like CUE-501 and ongoing research on CUE-102 for autoimmune diseases present avenues for partnership discussions with Cue Biopharma.

Strategic Partnerships Partnerships with pharmaceutical giant Ono Pharmaceutical Co to develop CUE-401 and CUE-501 signify an openness to collaborations, indicating a potential partnership or licensing opportunity.

Clinical-Stage Innovations Cue Biopharma's focus on developing a novel class of injectable biologics targeting disease-specific T cells within the patient’s body aligns with market trends towards personalized medicine, indicating potential interest from healthcare providers or investors.

Board of Directors Expansion The appointment of Pamela D. Garzone, an experienced pharmaceutical executive, to Cue Biopharma's board of directors hints at potential strategic guidance and valuable networking opportunities for future business engagements.

Similar companies to Cue Biopharma

Cue Biopharma Tech Stack

Cue Biopharma uses 8 technology products and services including WordPress, NetSuite, Google Font API, and more. Explore Cue Biopharma's tech stack below.

  • WordPress
    Content Management System
  • NetSuite
    E-commerce
  • Google Font API
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Lodash
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • RSS
    Miscellaneous
  • PHP
    Programming Languages

Media & News

Cue Biopharma's Email Address Formats

Cue Biopharma uses at least 2 format(s):
Cue Biopharma Email FormatsExamplePercentage
FLast@cuebio.comJDoe@cuebio.com
97%
First@cuebio.comJohn@cuebio.com
3%

Frequently Asked Questions

Where is Cue Biopharma's headquarters located?

Minus sign iconPlus sign icon
Cue Biopharma's main headquarters is located at 40 Guest Street Boston, Massachusetts 02135 US. The company has employees across 2 continents, including North AmericaOceania.

What is Cue Biopharma's phone number?

Minus sign iconPlus sign icon
You can contact Cue Biopharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cue Biopharma's stock symbol?

Minus sign iconPlus sign icon
Cue Biopharma is a publicly traded company; the company's stock symbol is CUE.

What is Cue Biopharma's official website and social media links?

Minus sign iconPlus sign icon
Cue Biopharma's official website is cuebiopharma.com and has social profiles on LinkedIn.

How much revenue does Cue Biopharma generate?

Minus sign iconPlus sign icon
As of October 2024, Cue Biopharma's annual revenue reached $7.5M.

What is Cue Biopharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Cue Biopharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cue Biopharma have currently?

Minus sign iconPlus sign icon
As of October 2024, Cue Biopharma has approximately 49 employees across 2 continents, including North AmericaOceania. Key team members include Chief Business Officer: P. N.Chief Medical Officer: M. L.Vice President Of Enterprise Operations And Portfolio Strategy Leader: A. A.. Explore Cue Biopharma's employee directory with LeadIQ.

What industry does Cue Biopharma belong to?

Minus sign iconPlus sign icon
Cue Biopharma operates in the Biotechnology Research industry.

What technology does Cue Biopharma use?

Minus sign iconPlus sign icon
Cue Biopharma's tech stack includes WordPressNetSuiteGoogle Font APIGoogle CloudLodashjQuery MigrateRSSPHP.

What is Cue Biopharma's email format?

Minus sign iconPlus sign icon
Cue Biopharma's email format typically follows the pattern of . Find more Cue Biopharma email formats with LeadIQ.

How much funding has Cue Biopharma raised to date?

Minus sign iconPlus sign icon
As of October 2024, Cue Biopharma has raised $12M in funding. The last funding round occurred on Sep 26, 2024 for $12M.

When was Cue Biopharma founded?

Minus sign iconPlus sign icon
Cue Biopharma was founded in 2014.
Cue Biopharma

Cue Biopharma

Biotechnology ResearchMassachusetts, United States11-50 Employees

Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) and biologics are designed to harness the body’s intrinsic immune system as T cell engagers without the need for ex vivo manipulation or broad systemic immune modulation.

Section iconCompany Overview

Headquarters
40 Guest Street Boston, Massachusetts 02135 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CUE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $12M

    Cue Biopharma has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Sep 26, 2024 in the amount of $12M.

  • $10M

    Cue Biopharma's revenue is in the range of $10M

Section iconFunding & Financials

  • $12M

    Cue Biopharma has raised a total of $12M of funding over 4 rounds. Their latest funding round was raised on Sep 26, 2024 in the amount of $12M.

  • $10M

    Cue Biopharma's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.